A comparable study indicated that FN1, the gene associated with C3 FN1+ TCs, served as a marker correlated with unfavorable outcomes, while another investigation revealed its involvement in regulating the advancement of ovarian cancer (Wei et al., 2021; Meagher et al., 2022). The gene discussed is FN1; the disease is ovarian carcinoma.